Source link : https://www.newshealth.biz/health-news/risk-for-preterm-birth-stops-maternal-rsv-vaccine-trial/
A phase 3 trial testing a maternal vaccine candidate for respiratory syncytial virus is stopped early because the risk of preterm births is higher in the candidate vaccine group than in the placebo group. By the time enrollment was stopped on February 25, 2022 because of the safety signal of preterm birth, 5328 pregnant women […]
Author : News Health
Publish date : 2024-03-13 21:09:52
Copyright for syndicated content belongs to the linked Source.
in Health